Business Context and Reporting Period
Company: flyExclusive, Inc. (FLYX)
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2026
Reporting Period: Event date January 9, 2026
Context: The Company, an emerging growth company incorporated in Delaware, announced the entry into a material underwriting agreement for a public offering of Class A Common Stock.
Key Financial Metrics and Transaction Details
- Shares Offered: 2,255,639 shares of Class A Common Stock.
- Public Offering Price: $6.65 per share.
- Over-allotment Option: Underwriter granted a 45-day option to purchase up to 222,833 additional shares at the same price.
- Expected Net Proceeds: Approximately $13.8 million (excluding over-allotment), after deducting underwriting discounts, commissions, and estimated offering expenses.
- Expected Closing Date: January 12, 2026.
- Lock-up Agreements: Board members and certain officers entered into 90-day lock-up agreements.
Note: This filing does not provide historical revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses solely on the capital raise transaction.
Material Changes Versus Prior Period
This filing reports a discrete corporate event (equity offering) rather than a comparative financial period. Consequently, there are no reported material changes in operating metrics (revenue, earnings, etc.) versus a prior comparable period within this document.
Guidance, Outlook, and Risks
- Management Commentary: The Company expects to close the offering on January 12, 2026, utilizing proceeds from the sale of common stock registered under Form S-3.
- Contingencies: The transaction is subject to the terms of the Underwriting Agreement, including customary representations, warranties, and indemnification provisions.
- Unusual Items: None reported beyond the standard terms of the underwriting agreement and the issuance of press releases on January 8 and 9, 2026.
Key Facts for Investor Verification
- Verify the final closing date and actual net proceeds received on or after January 12, 2026.
- Confirm whether the underwriter exercises the 45-day over-allotment option for an additional 222,833 shares.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific underwriting discounts and commission rates not detailed in the summary.
- Monitor the impact of the 90-day lock-up period on share liquidity and trading volume.
- Check subsequent filings for the specific allocation of the $13.8 million in net proceeds.